Literature DB >> 15765572

Correlation of in vitro-in vivo release rates for sustained release nevirapine implants in rats.

J Chen1, K Walters, P Ashton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15765572

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.

Authors:  John M Cortez; Rafaela Quintero; John A Moss; Martin Beliveau; Thomas J Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

2.  Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.

Authors:  Manjula Gunawardana; Mariana Remedios-Chan; Christine S Miller; Rob Fanter; Flora Yang; Mark A Marzinke; Craig W Hendrix; Martin Beliveau; John A Moss; Thomas J Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

Review 3.  Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research.

Authors:  Denise A Cobb; Nathan A Smith; Benson J Edagwa; JoEllyn M McMillan
Journal:  Expert Opin Drug Deliv       Date:  2020-07-06       Impact factor: 6.648

4.  Long-acting implants to treat and prevent HIV infection.

Authors:  Ethel D Weld; Charles Flexner
Journal:  Curr Opin HIV AIDS       Date:  2020-01       Impact factor: 4.061
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.